Together, these data suggest that γδ T cells and CD8+ T cells may play a key role of anti-inflammation and anti-tumor, and the CD8+ T cells appear to have been reprogrammed by the LSCC TME, enabling malignant cells to escape immune attacks. Here, CD8A is linked to neoplasm.